-transparent.png){kind=logo}
A solid phase reverse passive hemadsorption test (SP-RPHAd) for hepatitis B surface antigen detection is described. It was compared with a commercial reverse passive hemagglutination assay (Hepatest, Wellcome, U.K.). SP-RPHAd is four-fold less expensive than Hepatest and undiluted sera can be used instead of eight-fold diluted sera without risk of non-specific hemagglutination. Thus, the threshold of detection is lowered to about 5 ng/ml by SP-RPHAd.
Related Publications
G Duverlie, and
M Driencourt, and
C Roussel, and
P Daniel
April 1979,
Annals of the Academy of Medicine, Singapore,
G Duverlie, and
M Driencourt, and
C Roussel, and
P Daniel
May 1977,
Clinical chemistry,
G Duverlie, and
M Driencourt, and
C Roussel, and
P Daniel
February 1987,
American journal of clinical pathology,
G Duverlie, and
M Driencourt, and
C Roussel, and
P Daniel
January 1985,
Laboratornoe delo,
G Duverlie, and
M Driencourt, and
C Roussel, and
P Daniel
October 1976,
Journal of clinical pathology,
G Duverlie, and
M Driencourt, and
C Roussel, and
P Daniel
June 1973,
JAMA,
G Duverlie, and
M Driencourt, and
C Roussel, and
P Daniel
January 1979,
Clinical chemistry,
G Duverlie, and
M Driencourt, and
C Roussel, and
P Daniel
July 1973,
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.),
G Duverlie, and
M Driencourt, and
C Roussel, and
P Daniel
June 1974,
Lancet (London, England),
G Duverlie, and
M Driencourt, and
C Roussel, and
P Daniel
February 1987,
Tropical animal health and production,
